Invention Grant
US09242980B2 Lipidated immune response modifier compound compositions, formulations, and methods
有权
脂质化免疫应答调节剂化合物组合物，制剂和方法
- Patent Title: Lipidated immune response modifier compound compositions, formulations, and methods
- Patent Title (中): 脂质化免疫应答调节剂化合物组合物，制剂和方法
-
Application No.: US13817214Application Date: 2011-08-16
-
Publication No.: US09242980B2Publication Date: 2016-01-26
- Inventor: Paul D. Wightman
- Applicant: Paul D. Wightman
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- International Application: PCT/US2011/047901 WO 20110816
- International Announcement: WO2012/024284 WO 20120223
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K39/39 ; A61K31/437 ; A61K9/00 ; A61K9/10 ; A61K9/127 ; A61K31/47 ; A61K39/00 ; A61K47/26
Abstract:
The compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide is a useful drug compound for enhancing immune response and can be used, for example, as a vaccine adjuvant and a cancer treatment.
Public/Granted literature
- US20130230578A1 LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS Public/Granted day:2013-09-05
Information query
